ASB2 is abnormally downregulated in a mouse model for hypertrophic cardiomyopathy with an associated buildup of desmin levels due to loss of ASB2-directed proteosomal-mediated degradation in cardiomyocytes [70]. The gene discussed is DES; the disease is hypertrophic cardiomyopathy.